ng-nitroarginine methyl ester has been researched along with Stroke in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 9 (56.25) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Gouveia, A; Lagace, D; Lui, M; Wang, J | 1 |
Cheng, H; Ding, Z; Kong, Q; Li, C; Li, N; Li, Y; Liu, C; Liu, J; Liu, L; Mao, Y; Zhang, X; Zhao, Y | 1 |
Baumbach, J; Casas, AI; Egea, J; Elbatreek, M; Gomez-Rangel, V; Guney, E; Hassan, AA; Kleikers, PWM; Larsen, SJ; López, MG; Schmidt, HHHW | 1 |
Abdolghaffari, AH; Aleyasin, AR; Azizi, Y; Chabouk, L; Dehpour, AR; Gooshe, M; Hassanzadeh, GR; Partoazar, A; Payandemehr, B; Tofigh, S | 1 |
Dezawa, M; Fujimura, M; Kushida, Y; Niizuma, K; Sakata, H; Tominaga, T; Uchida, H | 1 |
Cribbs, DH; Gillen, DL; Kilday, K; Passos, GF; Vasilevko, V | 1 |
Daneshtalab, N; Smeda, JS | 1 |
Aronowski, J; Grotta, JC; Kasam, M; Misra, V; Savitz, SI; Schaar, K; Strong, R; Xi, X; Yang, B | 1 |
Friedman, A; Heinemann, U; Melamed-Book, N; Ofek, K; Schoknecht, K; Soreq, H | 1 |
Chen, J; Chen, S; Chen, Y; Raizada, MK; Shenoy, V; Xiao, X; Yi, D; Zhang, C; Zhao, B | 1 |
Kawata, K; Matsuda, K; Negishi, M; Sekiguchi, F; Shimamur, K; Shinomiya, K; Sunano, S; Yamamoto, K | 1 |
Chen, J; Chopp, M; Feldkamp, CS; Jiang, H; Katakowski, M; Li, Y; Lu, M; Wang, L; Wang, Y; Zhang, C; Zhang, ZG | 1 |
Baumbach, GL; Faraci, FM; Heistad, DD; Iida, S; Lavoie, JL; Sigmund, CD | 1 |
Furukawa, Y; Horiuchi, K; Kamiyama, S; Komai, M; Ohinata, K; Shirakawa, H; Watanabe-Kamiyama, M | 1 |
Ahmad, S | 1 |
Laverty, R; Ledingham, JM | 1 |
16 other study(ies) available for ng-nitroarginine methyl ester and Stroke
Article | Year |
---|---|
Combination of Endothelin-1 (ET-1) and L-NAME to Induce Murine Focal Cortical Stroke with Persistent Sensorimotor Deficits.
Topics: Animals; Disease Models, Animal; Endothelin-1; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Rats; Stroke; Vasoconstrictor Agents | 2022 |
HSPA12B promotes functional recovery after ischaemic stroke through an eNOS-dependent mechanism.
Topics: Animals; Brain Ischemia; Cell Proliferation; Enzyme Activation; Enzyme Inhibitors; Hippocampus; HSP70 Heat-Shock Proteins; Mice, Transgenic; Neovascularization, Physiologic; Neurogenesis; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Recovery of Function; Stroke; Survival Analysis; Up-Regulation | 2018 |
From single drug targets to synergistic network pharmacology in ischemic stroke.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Cell Death; Disease Models, Animal; Drug Combinations; Drug Discovery; Drug Synergism; Female; Male; Mice; NADPH Oxidase 4; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pyrazoles; Pyridones; Reactive Oxygen Species; Stroke | 2019 |
Hypoxia/ischemia a key player in early post stroke seizures: modulation by opioidergic and nitrergic systems.
Topics: Analgesics, Opioid; Animals; Brain Ischemia; Cell Hypoxia; Drug Synergism; GABA Antagonists; Male; Mice; Naltrexone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Seizures; Stroke | 2015 |
Experimental model of small subcortical infarcts in mice with long-lasting functional disabilities.
Topics: Animals; Cerebral Infarction; Disease Models, Animal; Endothelin-1; Internal Capsule; Male; Mice; Mice, SCID; NG-Nitroarginine Methyl Ester; Psychomotor Performance; Stroke; Time Factors | 2015 |
Experimental hypertension increases spontaneous intracerebral hemorrhages in a mouse model of cerebral amyloidosis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II; Animals; Blood Pressure; Brain; Cerebral Amyloid Angiopathy; Female; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Risk Factors; Stroke | 2016 |
Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthases in SHRsp with stroke.
Topics: Animals; Arginine; Biopterins; Blood Pressure; Cerebral Hemorrhage; Cerebrovascular Circulation; Enzyme Inhibitors; Homeostasis; Hypertension; Male; Middle Cerebral Artery; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Stroke; Vasodilation | 2010 |
Nitric oxide facilitates delivery and mediates improved outcome of autologous bone marrow mononuclear cells in a rodent stroke model.
Topics: Animals; Bone Marrow Transplantation; Cerebrovascular Circulation; Disease Models, Animal; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Perfusion; Rats; Stroke; Time Factors; Transplantation, Autologous; Treatment Outcome | 2012 |
Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling.
Topics: Acetylcholinesterase; Animals; Arterioles; Atropine; Calcium; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; HSP90 Heat-Shock Proteins; Male; Mecamylamine; Methysergide; Muscarinic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Reperfusion; Selective Serotonin Reuptake Inhibitors; Serotonin; Signal Transduction; Stroke; Vasodilation | 2012 |
Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy.
Topics: Acetophenones; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Cells, Cultured; Enzyme Inhibitors; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Peptides; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Renin; Stem Cell Transplantation; Stroke; Transduction, Genetic | 2013 |
Endothelium-dependent relaxation in pulmonary arteries of L-NAME-treated Wistar and stroke-prone spontaneously hypertensive rats.
Topics: Animals; Arginine; Blood Pressure; Body Weight; Cardiovascular Agents; Endothelium, Vascular; Enzyme Inhibitors; Genetic Predisposition to Disease; Hypertension; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroarginine; Nitroprusside; Pulmonary Artery; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Stroke; Vasodilation | 2002 |
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke.
Topics: Animals; Antibodies; Atorvastatin; Brain; Enzyme Inhibitors; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Male; Mitogen-Activated Protein Kinases; Neovascularization, Physiologic; Neuronal Plasticity; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrroles; Rats; Rats, Wistar; Signal Transduction; Stroke; Synapses; Vascular Endothelial Growth Factor Receptor-2 | 2003 |
Spontaneous stroke in a genetic model of hypertension in mice.
Topics: Angiotensinogen; Animal Feed; Animals; Blood Pressure; Brain; Circadian Rhythm; Disease Models, Animal; Female; Humans; Hypertension; Intracranial Hemorrhages; Mice; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Renin; Salts; Stroke | 2005 |
Antihypertensive effect of biotin in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Biotin; Coronary Vessels; Genetic Predisposition to Disease; Glucose Tolerance Test; Guanylate Cyclase; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Time; Vitamins | 2008 |
Acetazolamide and enalapril combination offers complete protection from nitric oxide-deficient stroke in stroke-prone spontaneously hypertensive rats.
Topics: Acetazolamide; Angiotensin-Converting Enzyme Inhibitors; Animals; Barium Compounds; Blood Pressure; Carbonic Anhydrase Inhibitors; Chlorides; Drug Interactions; Enalapril; Enzyme Inhibitors; Glyburide; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Inbred SHR; Stroke | 2000 |
Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Basilar Artery; Blood Pressure; Brain; Enalapril; Enzyme Inhibitors; Hypertension; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Stroke; Tetrazoles; Valine; Valsartan; Ventricular Function, Left | 2000 |